Submitted by Anonymous (not verified) on 5 November 2025 - 16:54
Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (previously Rivaroxaban Mylan), rivaroxaban, Date of authorisation: 12/11/2021, Revision: 10, Status: Authorised
Source: